A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes

Khalid Z. Alshali; Abdullah M. Karawagh

doi:10.15537/smj.2016.8.15800

Article Information

vol. 37 no. 8 834-842

DOI

https://doi.org/10.15537/smj.2016.8.15800

PubMed

27464858

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Published online August 1, 2016.

Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

Khalid Z. Alshali, MBChB, FRCPC ⇑ and
Abdullah M. Karawagh, MBBCh, FRCPC

From the Department of Medicine (Alshali), Faculty of Medicine, King Abdulaziz University, and the Department of Endocrinology (Karawagh), King Abdullah Medical Complex, Jeddah, Kingdom of Saudi Arabia

Address correspondence and reprint request to: Dr. Khalid Z. Alshali, Associate Professor, Consultant Endocrinologist, Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. E-mail: [email protected]

View Full Text